Experimental autoimmune motoneuron disease
- 1 September 1989
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 26 (3) , 368-376
- https://doi.org/10.1002/ana.410260310
Abstract
An animal model of disease of the lower motoneurons has been developed by inoculating guinea pigs with bovine motoneurons. Four of 9 immunized female animals and 4 of 5 immunized male animals developed symptoms of neuromuscular degeneration marked by weakness, evidence of denervation by electromyographic and morphological criteria, and a loss of motoneurons within the spinal cord. No inflammatory foci were noted within parenchyma or meninges of the central nervous system. The immunized guinea pigs developed high serum titers of IgG class antibodies to motoneurons. Immunohistochemical studies demonstrated the presence of IgG within spinal cord motoneurons and at the end‐plates of immunized animals. This experimental autoimmune motoneuron disease may provide important insights into the cause and pathogenesis of amyotrophic lateral sclerosis, a human motoneuron disease.This publication has 15 references indexed in Scilit:
- Uptake of plasma IgG by CNS motoneuronsNeurology, 1988
- Monoclonal IgM with unique specificity to gangliosides GM 1 and GD 1b and to lacto‐ N ‐tetraose associated with human motor neuron diseaseNeurology, 1988
- Retrograde transport and differential accumulation of serum proteins in motor neuronsNeurology, 1987
- Motor neuron disease and plasma cell dyscrasiaNeurology, 1986
- An immune-mediated guinea pig model for lower motor neuron diseaseJournal of Neuroimmunology, 1986
- Intraneuronal IgG in the central nervous systemJournal of the Neurological Sciences, 1986
- An improved method for the bulk isolation of spinal motoneuronesJournal of Neuroscience Methods, 1985
- A note on the use of picric acid-paraformaldehyde-glutaraldehyde fixative for correlated light and electron microscopic immunocytochemistryNeuroscience, 1982
- AUTOIMMUNE AETIOLOGY FOR MYASTHENIC (EATON-LAMBERT) SYNDROMEThe Lancet, 1981
- Myasthenia GravisNew England Journal of Medicine, 1977